Welcome!

The primary goal of the Laboratory of Neuropsychopharmacology is to understand the cellular and molecular basis and treatment of complex psychiatric diseases including depression, anxiety disorders and schizophrenia with the ultimate goals of development of novel therapeutics and increasing the efficacy of current treatments. To address these issues, we use a variety of molecular, cellular, pharmacological, behavioral and imaging techniques in laboratory animals and humans.

(STANDING) Dr. Charles Nemeroff, Faketa Zejnelovic, Hongyan Qu, Dr. Jianjun Wang, Dr. Gretchen Neigh, Dr. Becky Kinkead
Mallory Shurte, Dr. K.V. Thrivikraman, Emily Hardy, Madiha Raees, Dr. Michael Owens,
(SITTING) Elizabeth Martin, Chase Bourke, Lucy Guillory, Nicola Hanson, Swati Rogers
(NOT PICTURED) Susan Plott, Catherine Capello